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COMPARISON OF FUNCTIONAL OUTCOMES BETWEEN THE FIRST AND 1 
SECOND KNEE IN STAGED BILATERAL TOTAL KNEE ARTHROPLASTY WITH 2 
DIVERSE INTERVALS BETWEEN STAGES 3 
 4 
ABSTRACT 5 
Background: To analyze if the length of interval time between stages influenced functional 6 
and quality of life outcomes in patients with staged bilateral primary TKA. 7 
Methods: Retrospective comparative study between 93 patients with an interval between 8 
stages of 6-8 months (6-month group), 112 of 12-14 months (1-year group), and 108 of 24-26 9 
months (2-year group). Outcome variables were Knee Society scores (KSS), Western Ontario 10 
and McMaster Universities (WOMAC), Short-Form (SF12) and patient satisfaction. 11 
Results: Overall, the mean follow-up for the first TKA was 8.2 (range, 7-10) years, and for 12 
the second TKA 6.7 (range, 5-10) years. At last follow-up, functional and patient-related 13 
outcomes were similar for both knees, regardless of the interval. However, mental score and 14 
patient satisfaction were significantly better for the second than for the first TKA in the 2-year 15 
group. Age did not correlate significantly with the functional scores but was significantly 16 
correlated with the mental score. 17 
Conclusion: The performing staged bilateral TKA with a wide interval between surgeries 18 
provided equivalent functional outcomes and quality of life for both knees. Postoperative 19 
outcomes were not affected by the length of the time interval between procedures or age. Our 20 
results can help the surgeon to inform to the patients reliably about they can expect in the 21 
delay of a second knee replaced. Thus patients could make an informed decision. 22 
Key words: Total knee arthroplasty; Staged bilateral; Functional outcome; Quality of life; 23 
Age  24 
 25 
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INTRODUCTION 26 
Total knee arthroplasty (TKA) is an effective treatment to relieve pain and restore physical 27 
functioning in patients with end-stage knee osteoarthritis [1]. Many patients with knee 28 
osteoarthritis have bilateral symptoms [2], with a prevalence of severe bilateral involvement 29 
as high as 19% [3]. In such patients, the surgeries can be performed either simultaneously or 30 
in a staged operation with a variable length of time between each arthroplasty. However, 31 
choosing between both bilateral procedures is controversial [4]. The decision to proceed with 32 
bilateral surgery is made by the patient following discussion with the surgeon, on the basis of 33 
the expectations, patient’s physical condition and relative contraindications. Thus, many 34 
elderly patients with bilateral osteoarthritis can decide to have TKA on the contralateral side 35 
after the remission phase of the first stage [5]. Sesen et al [6] reported a refusal rate for the 36 
second TKA of 37 %, and the patients older than 70 years had a higher refusal rate compared 37 
to younger patients. On the other hand, many other patients present severe stage in one knee 38 
but mild to moderate in the contralateral knee, which does not require surgery until after a 39 
long time [7].  40 
Many studies have been published on bilateral TKA, but most of them focused on 41 
complications and socioeconomic implications of simultaneous versus staged TKA [8]. Some 42 
others have compared overall functional outcomes between patient cohorts underwent these 43 
bilateral procedures, although most of them involved relatively small cohorts of patients or 44 
short follow-up [9,10]. However, studies comparing the functional outcomes of the first and 45 
second knee in patients underwent staged bilateral procedures are few [9,11,12]. In addition, 46 
the majority of patients included in those studies had an interval between stages less than 12 47 
months, and follow-up was up to 1 year in all but one study [11]. Thus, although objective 48 
outcomes for each knee may be reliable, quality of life outcomes for each knee may be 49 
difficult to assess if the interval between surgeries was short. To our knowledge, no studies 50 
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had compared the functional and patient-reported outcomes between both knees in patients 51 
underwent staged bilateral TKA with a relatively long time interval between stages and a 52 
medium-term follow-up.  53 
The aim of this study was to analyze if the length of interval time between stages influenced 54 
functional and quality of life outcomes in patients with staged bilateral primary TKA. 55 
 56 
PATIENTS AND METHODS 57 
This was a retrospective cohort study of patients prospectively assessed. The study was 58 
approved by our Institutional Review Board and informed consent was required for a new 59 
evaluation. Patients who underwent bilateral TKA at our centre between 2006 and 2012 were 60 
identified in our departmental arthroplasty database. This database prospectively collected 61 
clinical and radiological data in a standardized manner with annual postoperative follow-up 62 
for at least 5 years. TKA was recommended to patients who had radiologically Kellgren and 63 
Lawrence grade III or IV knee osteoarthritis with related symptoms. In the case of bilateral 64 
knee involvement, the first procedure was selected based on symptoms and patient preference, 65 
and the time interval between stages was decided based on surgeon's recommendations and 66 
patient preference. Simultaneous bilateral TKA was not performed at our centre. 67 
Inclusion criteria were staged bilateral primary TKA, aged over 60 years, and minimum 68 
postoperative follow-up of 5 years for each knee. Exclusion criteria were posttraumatic or 69 
inflammatory arthritis, neurological disorder or need for constrained TKA in any knee. Like 70 
other [12], because the objective was to compare functional and patient-related outcomes 71 
between both knees, patients who had revision TKA were also excluded to limit outcome 72 
bias. 73 
There were 351 patients with staged bilateral TKA. Of these, 18 had surgical revision of one 74 
knee and 20 other patients had one knee with follow-up less than 5 years. All these 38 patients 75 
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were excluded. The 313 remaining patients were classified into 3 groups according to the 76 
interval time between stages. There were 93 patients with an interval between 6 and 8 months 77 
(6-month group), 112 between 12 and 14 months (1-year group), and 108 between 24 and 26 78 
months (2-year group). Baseline characteristics of each group are shown in Table 1. 79 
 80 
Surgical protocol 81 
Surgeries were performed by several consultant surgeons, although the same surgeon operated 82 
both knees for the same patient. In addition, all procedures were standardized at our centre 83 
and the same surgical techniques and postoperative protocols were used for both knees of all 84 
patients. All surgeries were performed in operating room with laminar flow, under spinal 85 
anaesthesia. A standard anterior midline skin incision and medial parapatellar arthrotomy 86 
were used in all patients. Standard operative techniques with intramedullar alignments for 87 
femur and tibia were used for all patients. The same modular TKA systems were used in all 88 
patients (Trekking, Samo, Italy). Fixation was hybrid (cementless femur and cemented tibia). 89 
Depending on the ligament balance at the time of surgery, a cruciate-retaining (CR) or 90 
posterior-stabilized (PS) model was used. All patellae were routinely resurfaced with an all-91 
polyethylene cemented design. 92 
According to the standard protocol, all patients received antibiotic prophylaxis with first 93 
generation cephalosporin for 24 hours (started 1 hour prior to skin incision) and 94 
thromboembolic prophylaxis with low-molecular-weight heparin for 30 days. Standardized at 95 
our centre, continuous passive knee motion started on the first postoperative day and from the 96 
third day active motion under the supervision of the therapist and full weight-bearing were 97 
allowed. 98 
 99 
Evaluations 100 
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All patients had been prospectively assessed, clinical and radiologically, preoperatively and 101 
postoperatively at each annual visit. Functional assessment was assessed by the Knee Society 102 
scores (KSS) [13], and patient-reported outcomes with the Western Ontario and McMaster 103 
Universities (WOMAC) [14] and Short-Form (SF12) [15] questionnaires validated for our 104 
country. The WOMAC score was transformed to a 0-100 scale, so a higher value implies a 105 
better outcome, and the result was shown overall for pain and function. Patient satisfaction for 106 
each knee was measured at the time of the latest follow-up with a 0-10 visual analogue scale 107 
(VAS). Comorbidity was assessed by the American Society of Anesthesiologists (ASA) 108 
scores [16]. 109 
Radiological evaluation was performed using standing anteroposterior, lateral and standard 110 
skyline views. The latest radiographs were assessed for presence and location of radiolucent 111 
lines on the basis of Knee Society zones [17]. 112 
 113 
Statistical analysis 114 
A posteriori analysis of statistical power was performed with a non-inferiority test. 115 
Considering our sample size, a minimal clinically important difference [18] of 10 with 116 
standard deviation of 10 for the physical component summary of SF12, and alpha 117 
error of 0.05 %, the study had a power of 84%, which was considered appropriate. 118 
Statistical analyses were performed with SPSS software v. 15.0 (SPSS Inc., Chicago, USA). 119 
Normal distribution was determined by the Kolmogorov-Smirnov test.  For paired comparison 120 
between pre- and post-operative and between first and second knees data, the McNemar test 121 
was used in categorical variables, and the paired t-test or non-parametric Wilcoxon signed-122 
rank test in continuous variables. Variance analysis (Anova) was use for comparison between 123 
groups. Correlations were made by the Pearson coefficient test. Statistical significance was 124 
considered for p values less than 0.05. 125 
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 126 
RESULTS 127 
Overall, the mean follow-up for the first staged TKA was 8.2 (range, 7-10) years, and for the 128 
second TKA 6.7 (range, 5-10) years. All the knees of each group improved significantly from 129 
preoperative to the last follow-up. 130 
In 6-month and 1-year groups (Table 2), there were no significant differences in objective or 131 
patient-related scores between the first and second knee (all, p< 0.05). In 2-year group, there 132 
were no significant differences in KSS scores, ROM, WOMAC or SF12-physical scores (all, 133 
p< 0.05), but SF12-mental score was significantly higher in the second knee compared to the 134 
first knee (p= 0.041). 135 
Comparing the three groups (Table 2), there were no significant differences between the first 136 
knees or the second knees in any score, except in patient satisfaction. Regarding patient 137 
satisfaction at the last follow-up for each knee (Table 2), there was no significant difference 138 
between the first and second knee in the 6-month group (p= 0.411) and 1-year group (p= 139 
0.055). However, patient satisfaction was significantly higher in the second knee compared to 140 
the first knee (p= 0.012). Comparing the three groups, there was no significant difference in 141 
patient satisfaction for the first knee (p= 0.454). However, although for the second knee there 142 
were no significant differences between 1-month and 1-year groups (p= 0.181) or between 1-143 
year and 2-year groups (p= 0.140), patient satisfaction was significantly higher for the second 144 
knee in the 2-year group compared with the 6-month group (p= 0.030). Comparing TKA 145 
types, CR or PS, there were no significant differences in satisfaction (p= 0.732). 146 
Regarding the second staged TKA, the interval time between stages did not influence the 147 
KSS-knee (r= 0.4, p= 0.425) or KSS-function (r= 0.5, p= 0.237) score at the last follow-up. 148 
At the last follow-up, there were no significant differences between the TKA types (CR 149 
versus PS) in KSS-knee (p= 0.612), KSS-function (p= 0.497), ROM (p= 0.116), WOMAC 150 
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(p= 0.197) or SF12 (p= 0.392). Likewise, the age at the time of the first TKA did not correlate 151 
significantly with the KSS-function (r= 0.7, p= 0.317), WOMAC-function (r= -0.3, p= 0.637) 152 
or SF12-physical (r= -0.4, p= 0.086) scores at the last follow-up in either the first or second 153 
staged TKA. However, the age at the time of the second TKA was significantly correlated 154 
with SF12-mental score at the last follow-up in the 2-year group (r= -0.6, p= 0.040).  155 
 156 
DISCUSSION 157 
The main finding of the present study was that functional and quality of life scores were not 158 
significantly different between the first and second knee in any time interval. However, 159 
mental score and patient satisfaction were significantly better for the second than for the first 160 
TKA in the 2-year group but not in shorter intervals. Likewise, patient satisfaction for the 161 
second knee was significantly higher in the 2-year group compared to 6-month group. Age at 162 
the time of the first TKA did not correlate significantly with the functional scores for the 163 
second knee, but was significantly correlated with the mental score.  164 
Like us, Gabr et al [19] found similar KSS, WOMAC and SF12-physical scores between 165 
knees at the last follow-up, and better SF12-mental score for the second knee compared to the 166 
first. Other studies reported no significant differences between both knees at the last follow-167 
up [9,11]. Like us, Scott et al [20] found higher satisfaction for the second TKA.   168 
Many patients have bilateral symptomatic knee osteoarthritis [21]. For these patients, 169 
simultaneously or staged bilateral TKA has been proposed. However, the reported results 170 
have been conflicting, such as similar [23,24], better [10], or worse [25] outcomes with 171 
simultaneous TKA compared to staged bilateral TKA. Moreover, it has been reported that 172 
patients undergoing bilateral simultaneous TKA tend to be younger and have better health 173 
status [3,26]. The decision to proceed with simultaneous or staged bilateral surgery must be 174 
done by the patient after receiving information from the surgeon, and it based on the physical 175 
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condition and expectations of the patient. Sesen et al [6] reported that 37% of patients refused 176 
the second TKA, especially patients older than 70 years. On the other hand, many other 177 
patients with unilateral TKA present only mild to moderate symptoms in the contralateral 178 
knee that does not require surgery in that time [7]. Subsequent arthroplasty of the contralateral 179 
knee following unilateral TKA has been reported in 36% of patients [27,28] with a wide 180 
interval between surgeries [29]. Thiam et al [30] reported that not all patients with bilateral 181 
knee osteoarthritis accepted bilateral TKA because unilateral TKA could restore quality of 182 
life. These authors found also that 28% of patients with bilateral knee osteoarthritis did not 183 
return for the second TKA within 2 years. Moreover, the patient’s experience with the first 184 
TKA has shown to have influence on the decision for contralateral surgery [5]. 185 
Some authors [5,19] have reported higher patient expectation for the second than for the first 186 
TKA. Gabr et al [20] found improved function and psychological well-being after the second 187 
surgery. Becker et al [31] reported that patient satisfaction was correlated with the functional 188 
outcomes, and the indication for TKA should consider the general health and emotional role 189 
in order to predict patient's outcome. 190 
Time interval between surgeries did not influence the results in our study. A recent national 191 
database study [26] reported a ratio of simultaneous to staged bilateral TKA of 1:4, and 94% 192 
of staged bilateral TKA, and other recent study [32] found no significant differences in 193 
functional outcomes or complication rate between surgery interval from 3 months to 1 year. 194 
Moreover, many patients decide to have TKA on the contralateral side after the remission 195 
phase of the first stage [5]. A study [33] of patients with unilateral TKA reported that the 196 
nonoperated limb tended to weaken after 2 years of surgery, possibly representing changes 197 
resulting from aging and progression of osteoarthrosis in some patients with unilateral TKA. 198 
In the present study, age did not influence outcomes. Abram et al [9] also reported that age 199 
did not affect the postoperative score in either the first or second staged TKA. 200 
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Strengths of the present study included the analysis of a single-centre with standardized 201 
surgical and postoperative management. The size of our samples provided adequate statistical 202 
power to detect significant differences. To our knowledge, this was the first study comparing 203 
diverse intervals between TKA. In addition, this study had the longest follow-up published to 204 
date comparing both knees. However, this study has also several limitations. Firstly, the study 205 
was retrospective. Nevertheless, the data had been collected prospectively in a systematic and 206 
standardized way, so the number of variables of interest was not limited. The cohort consisted 207 
in selected patients due to the exclusion of those who need revision TKA. This was done in an 208 
effort to minimize variables within the study population and thereby enhance the isolation of 209 
knee outcome parameters. We believe that this fact enhanced the obtained comparative 210 
results. In a study such as this, the patients compared themselves in the first and second knee. 211 
Therefore, the patients could have difficulty discerning which of the two knees had a greater 212 
or lesser effect on their quality of life. 213 
 214 
CONCLUSION 215 
This study suggested that performing staged bilateral TKA with a wide interval between 216 
surgeries provided equivalent functional outcomes and quality of life for both knees. 217 
Postoperative functional outcomes and quality of life were not affected by the length of the 218 
time interval between procedures or age. Our results can help the surgeon to inform to the 219 
patients reliably about they can expect in the delay of a second knee replaced. Thus patients 220 
could make an informed decision. 221 
 222 
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Table 1. Preoperative data at the time of each surgery 313 
 6-month group 
n= 93 
1-year group 
n= 112 
2-year group 
n= 108 
p-value 
Gender, F/M 69/24 79/33 77/31 0.833 
ASA, I-II/III-IV 71/22 81/31 74/34 0.467 
BMI, kg/m2 
  1st knee 
  2nd knee 
  p-value 
 
31.2 (5.9) 
30.4 (6.1) 
0.364 
 
30.9 (6.3) 
31.4 (6.4) 
0.556 
 
30.6 (6.7) 
31.7 (5.8) 
0.197 
 
0.798 
0.296 
ROM, degrees 
  1st knee 
  2nd knee 
  p-value 
 
88.4 (11.3) 
89.9 (12.1) 
0.383 
 
89.2 (10.8) 
90.4 (12.6) 
0.445 
 
89.8 (10.6) 
91.2 (11.3) 
0.348 
 
0.661 
0.739 
KSS-knee score 
  1st knee 
  2nd knee 
  p-value 
 
39.4 (13.7) 
41.2 (14.3) 
0.379 
 
40.4 (13.3) 
42.3 (15.1) 
0.318 
 
41.8 (14.4) 
44.3 (13.8) 
0.194 
 
0.463 
0.299 
KSS-function score 
  1st knee 
  2nd knee 
  p-value 
 
40.8 (12.7) 
43.5 (13.2) 
0.156 
 
41.7 (12.8) 
42.8 (13.6) 
0.533 
 
42.9 (13.8) 
45.5 (12.7) 
0.151 
 
0.522 
0.294 
WOMAC 
  1st knee 
  2nd knee 
  p-value 
 
40.3 (10.1) 
42.4 (11.2) 
0.181 
 
41.2 (9.9) 
42.9 (11.7) 
0.241 
 
41.7 (9.6) 
43.8 (12.4) 
0.165 
 
0.599 
0.692 
SF12-physical 
  1st knee 
  2nd knee 
  p-value 
 
29.7 (8.3) 
31.3 (10.1) 
0.239 
 
31.1 (8.4) 
33.3 (10.3) 
0.081 
 
30.4 (7.8) 
34.6 (9.4) 
0.001 
 
0.473 
0.064 
SF12-mental 
  1st knee 
  2nd knee 
  p-value 
 
36.4 (12.6) 
38.7 (10.3) 
0.174 
 
36.9 (10.7) 
39.3 (10.1) 
0.085 
 
38.4 (9.4) 
41.3 (9.6) 
0.025 
 
0.390 
0.148 
Continuous data as mean (SD).  314 
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Table 2. Outcomes for both TKA 319 
 320 
 6-month group 1-year group 2-year group p-value 
KSS-knee 
   1st knee 
   2nd knee 
   p-value 
 
86.1 (7.1) 
86.7 (8.2) 
0.594 
 
87.0 (7.9) 
85.9 (9.1) 
0.335 
 
85.9 (7.1) 
86.2 (6.4) 
0.744 
 
0.504 
0.773 
KSS-function 
   1st knee 
   2nd knee 
   p-value 
 
86.3 (8.2) 
87.0 (9.1) 
0.582 
 
86.9 (8.4) 
88.1 (9.8) 
0.326 
 
85.6 (9.7)  
87.3 (7.9) 
0.159 
 
0.773 
0.656 
ROM 
   1st knee 
   2nd knee 
   p-value 
 
102.6 (9.8) 
105.5 (10.3) 
0.051 
 
104.7 (11.1) 
102.9 (10.0) 
0.203 
 
101.8 (10.6) 
104.1 (11.7) 
0.131 
 
0.112 
0.224 
WOMAC 
   1st knee 
   2nd knee 
   p-value 
 
82.5 (11.2) 
84.3 (12.3) 
0.298 
 
86.2 (12.4) 
87.1 (10.9) 
0.564 
 
83.4 (13.5) 
85.1 (12.9)  
0.345 
 
0.081 
0.123 
SF12-physical 
   1st knee 
   2nd knee 
   p-value 
 
43.9 (9.4) 
44.6 (8.8) 
0.601 
 
44.2 (9.1) 
45.7 (9.4) 
0.226 
 
43.8 (8.7) 
44.3 (8.6) 
0.671 
 
0.943 
0.477 
SF12-mental 
   1st knee 
   2nd knee 
   p-value 
 
44.3 (10.2) 
45.6 (10.6) 
0.395 
 
44.8 (10.3) 
46.4 (9.8) 
0.234 
 
45.1 (9.5) 
47.6 (8.4) 
0.041 
 
0.850 
0.329 
Satisfaction 
   1st knee 
   2nd knee 
   p-value 
 
7.3 (1.5) 
7.1 (1.8) 
0.411 
 
7.0 (1.7) 
7.4 (1.4) 
0.055 
 
7.1 (1.9)  
7.7 (1.6)  
0.012 
 
0.454 
0.030 
Data as mean (SD) 321 
 322 
